Inventaire - your friends and communities are your best library

Phase II trial of dose-adjusted EPOCH in untreated systemic anaplastic large cell lymphoma

author

Stefania Pittaluga

Elaine Jaffe

1943 -

Wyndham H. Wilson

Kieron Dunleavy

Margaret Shovlin

Seth M Steinberg

Mark Roschewski

published in: Haematologica

date of publication: 2015-10-30

main subject: phase II clinical trial, epoch

Cites articles 15

Date

Title

Authors

2014-06-03

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

Elaine Jaffe, Rhett P. Ketterling, James R Cerhan, Matthew J. Maurer, Andrew L Feldman, Wyndham H. Wilson, Liuyan Jiang, Alina Nicolae
2013-11-01

Low-intensity therapy in adults with Burkitt's lymphoma

Elaine Jaffe, Stefania Pittaluga, Wyndham H. Wilson, Kieron Dunleavy, Margaret Shovlin, Seth M Steinberg, Cliona Grant
2013-04-01

Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma

Stefania Pittaluga, Elaine Jaffe, Wyndham H. Wilson, Kieron Dunleavy, Seth M Steinberg, Cliona Grant, Clara C Chen, Ranjana H. Advani
2012-10-08

Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trials

Olivier Hermine, Philippe Gaulard, Corinne Haioun
2012-09

Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01

Jan Delabie, Harald Holte, Hans Hagberg
2011-12-01

A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype

Andrew D Zelenetz, Wyndham H. Wilson, David D. Hurd, Bruce D. Cheson
2011-04-14

Peripheral T-cell lymphoma

Pier Luigi Zinzani, Randy D Gascoyne, Julie M Vose, Kensei Tobinai, Francine M Foss
2010-12-01

New strategies in peripheral T-cell lymphoma: understanding tumor biology and developing novel therapies

Owen A O'Connor, Wyndham H. Wilson, Susan E Bates, Richard L Piekarz, Kieron Dunleavy, John E Janik
2010-07-21

Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group

Michael Pfreundschuh, Andreas Rosenwald
2008-07-14

International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes

Julie M Vose, James O Armitage, Dennis D Weisenburger
2008-04-02

ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

Fred A. Ullrich, Julie M Vose, Randy D Gascoyne, James O Armitage, Dennis D Weisenburger, Joseph M Connors, Elaine Jaffe, Stefano A Pileri, Lisa M Rimsza, Kerry J Savage, Nancy Lee Harris, Mukesh Chhanabhai, International Peripheral T-Cell Lymphoma Project
2008-06-01

Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers

Louis M Staudt, Elaine Jaffe, Stefania Pittaluga, Wyndham H. Wilson, Kieron Dunleavy, Nicole Grant, Seth M Steinberg, Mark Raffeld, Bruce A Chabner
2007-01-22

Revised response criteria for malignant lymphoma.

Lena Specht, Randy D Gascoyne, Julie M Vose, Joseph M Connors, Richard T. Hoppe, Kensei Tobinai, Andrew C. Mitchell, Sandra A Van Horn, Beate Pfistner, Bruce D. Cheson, Malik E. Juweid, Bertrand Coiffier
2004-06-17

Elevated serum-soluble interleukin-2 receptor levels in patients with anaplastic large cell lymphoma.

Stefania Pittaluga, Elaine Jaffe, Wyndham H. Wilson, Thomas Waldmann, Nicole Grant, Mark Raffeld
1996-01-01

High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining

Article - wd:Q43009546

Welcome to Inventaire

the library of your friends and communities

learn more